Concentration of endogenous estrogens and estrogen metabolites in the NCI-60 human tumor cell lines

Genome Medicine

Volumn 4, Issue 4, 2012, Pages

  Xu, Xia ^a   Veenstra, Timothy D ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE;

ARTICLE; BODY FLUID; BREAST TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; COLON TUMOR; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; KIDNEY TUMOR; LEUKEMIA; LIQUID CHROMATOGRAPHY; LUNG NON SMALL CELL CANCER; MELANOMA; METABOLITE; OVARY TUMOR; PRIORITY JOURNAL; PROSTATE TUMOR; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

EID: 84860487925     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm330     Document Type: Article

References (35)

1. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 2008, 630:148-165. 10.1007/978-0-387-78818-0_10, 18637490.
2. Cavalieri EL, Rogan EG. Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol 2010, 6:75-91. 10.2217/fon.09.137, 20021210.
3. Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci 2009, 1155:194-205. 10.1111/j.1749-6632.2009.04116.x, 2782616, 19250205.
4. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol 2009, 36:524-531. 10.1053/j.seminoncol.2009.10.004, 2818861, 19995644.
5. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 2001, 1:1-12.
6. Ellem SJ, Risbridger GP. Aromatase and regulating the estrogen:androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 2010, 118:246-251. 10.1016/j.jsbmb.2009.10.015, 19896534.
7. Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and its role in gastrointestinal health and disease. Int J Colorectal Dis 2009, 24:1367-1375. 10.1007/s00384-009-0785-0, 19655153.
8. Hojo Y, Murakami G, Mukai H, Higo S, Hatanaka Y, Ogiue-Ikeda M, Ishii H, Kimoto T, Kawato S. Estrogen synthesis in the brain--role in synaptic plasticity and memory. Mol Cell Endocrinol 2008, 290:31-43. 10.1016/j.mce.2008.04.017, 18541362.
9. Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN, Caparrotta L, Martinuzzi A, Ragazzi E, Ghelli A, Sadun AA, d'Amati G, Carelli V. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011, 134:220-234. 10.1093/brain/awq276, 3025718, 20943885.
10. Felty Q, Yoo C, Kennedy A. Gene expression profile of endothelial cells exposed to estrogenic environmental compounds: implications to pulmonary vascular lesions. Life Sci 2010, 86:919-927. 10.1016/j.lfs.2010.04.007, 2916066, 20416326.
11. Merklinger-Gruchala A, Ellison PT, Lipson SF, Thune I, Jasienska G. Low estradiol levels in women of reproductive age having low sleep variation. Eur J Cancer Prev 2008, 17:467-472. 10.1097/CEJ.0b013e3282f75f67, 18714190.
12. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev 2000, 21:40-54. 10.1210/er.21.1.40, 10696569.
13. Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009, 30:343-375. 10.1210/er.2008-0016, 19389994.
14. Krahn-Bertil E, Dos Santos M, Damour O, Andre V, Bolzinger MA. Expression of estrogen-related receptor beta (ERRβ) in human skin. Eur J Dermatol 2010, 20:719-723.
15. Plewig G, Cunliffe WJ, Binder N, Höschen K. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. Contraception 2009, 80:25-33. 10.1016/j.contraception.2009.02.016, 19501212.
16. Shu YY, Maibach HI. Estrogen and skin: therapeutic options. Am J Clin Dermatol 2011, 12:297-311. 10.2165/11589180-000000000-00000, 21714580.
17. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol 2009, 20:358-364.
18. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989, 44:833-839. 10.1002/ijc.2910440515, 2583865.
19. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008, 9:385-391. 10.1016/S1470-2045(08)70100-1, 18374292.
20. Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG. Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 2007, 79:7813-7821. 10.1021/ac070494j, 17848096.
21. Blonder J, Johann DJ, Veenstra TD, Xiao Z, Emmert-Buck MR, Ziegler RG, Rodriguez-Canales J, Hanson JA, Xu X. Quantitation of steroid hormones in thin fresh frozen tissue sections. Anal Chem 2008, 80:8845-8852. 10.1021/ac801402a, 18937426.
22. O'Donnell AJM, Macleod KG, Burns DJ, Smyth JF, Langdon SP. Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr Relat Cancer 2005, 12:851-866. 10.1677/erc.1.01039, 16322326.
23. Danel L, Vincent C, Rousset F, Klein B, Bataille R, Flacher M, Durie BGM, Revillard JP. Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. J Steroid Biochem 1988, 30:363-367. 10.1016/0022-4731(88)90124-0, 3260311.
24. Danel L, Cordier G, Revillard JP, Saez S. Presence of estrogen binding sites and growth-stimulating effect of estradiol in the human myelogenous cell line HL60. Cancer Res 1982, 42:4701-4705.
25. Hendrickse CW, Jones CE, Donovan IA, Neoptolemos JP, Baker PR. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg 1993, 80:636-640. 10.1002/bjs.1800800531, 8518910.
26. Verma MK, Miki Y, Sasano H. Aromatase in human lung cancer. Steroids 2011, 76:759-764. 10.1016/j.steroids.2011.02.020, 21392519.
27. Suzuki T, Abe K, Suzuki S, Niikawa H, Iida S, Hata S, Akahira J, Mori K, Evans DB, Kondo T, Yamada-Okabe H, Sasano H. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment. Cancer Res 2010, 70:6659-6669. 10.1158/0008-5472.CAN-09-4653, 20710045.
28. Miki Y, Abe K, Suzuki S, Suzuki T, Sasano H. Suppression of estrogen actions in human lung cancer. Mol Cell Endocrinol 2011, 340:168-174. 10.1016/j.mce.2011.02.018, 21354461.
29. Stoica A, Hoffman M, Marta L, Voiculetz N. Estradiol and progesterone receptors in human cutaneous melanoma. Neoplasma 1991, 38:137-146.
30. Miller JG, Gee J, Price A, Garbe C, Wagner M, MacNeil S. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in progression of malignant melanoma. Melanoma Res 1997, 7:197-208. 10.1097/00008390-199706000-00003, 9195558.
31. Piantelli M, Maggiano N, Ricci R, Larocca LM, Capelli A, Scambia G, Isola G, Natali PG, Ranelletti OF. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Inv Dermatol 1995, 105:248-253.
32. Sarti MSMV, Visconti MA, Castrucci AML. Biological activity and binding of estradiol to SK-MEL 23 human melanoma cells. Braz J Med Biol Res 2004, 37:901-905. 10.1590/S0100-879X2004000600016, 15264034.
33. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282. 10.1056/NEJMra050776, 16421368.
34. Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakim A, Yin P, Ishikawa H, Amin S, Imir G, Gurates B, Attar E, Reierstad S, Innes J, Lin Z. Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol 2007, 106:81-96. 10.1016/j.jsbmb.2007.05.027, 2766613, 17590327.
35. Holbeck S, Chang J, Best AM, Bookout AL, Mangelsdorf DJ, Martinez ED. Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Mol Endocrinol 2010, 24:1287-1296. 10.1210/me.2010-0040, 2875807, 20375240.